Sang-Yong Lee

Title: Sang-Yong Lee: Innovator in Pharmaceutical Composition

Introduction

Sang-Yong Lee, based in Gyeonggi-do, South Korea, is an esteemed inventor known for his contributions in the field of pharmaceuticals. With a focus on nasal administration, he holds a noteworthy patent that combines innovation and utility in drug formulation.

Latest Patents

Sang-Yong Lee has been granted one patent titled "Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration." This invention provides a unique pharmaceutical composition that includes the active ingredients mometasone furoate and azelastine hydrochloride, which are used for nasal treatments. Notably, the composition incorporates thaumatin as an agent to reduce bitterness and irritation, enhancing patient compliance and experience.

Career Highlights

Sang-Yong Lee is currently associated with Hanlim Pharmaceutical Co., Ltd., where he plays a pivotal role in research and development. His work is essential in advancing therapeutic options in the pharmaceutical industry, showcasing his commitment to innovation and public health.

Collaborations

In his professional journey, Sang-Yong Lee collaborates closely with colleagues such as Geun-Hyeog Lee and Byong-Sun Choi. Together, they contribute to significant breakthroughs and advancements in drug formulation, demonstrating the power of teamwork in scientific research and development.

Conclusion

With a dedicated approach to pharmaceutical innovation, Sang-Yong Lee's work exemplifies the intersection of science and practical application. His contributions, especially in enhancing nasal drug formulations, reflect not only his inventiveness but also his commitment to improving patient outcomes in healthcare.